Immune Design Receives $60,000,000 New Funding Round

  • Feed Type
  • Date
    7/24/2014
  • Company Name
    Immune Design
  • Mailing Address
    1616 Eastlake Ave. E Seattle, WA 98102 USA
  • Company Description
    One of the greatest impacts on human health can be achieved by regulating the activity of the immune system. Recent advances in the field of molecular immunology have created new ways to treat infectious disease, cancer, allergy and autoimmunity. Immune Design (NASDAQ: IMDZ) is using this knowledge to discover and develop therapeutics that will protect and save lives world-wide.
  • Website
    http://www.immunedesign.com
  • Transaction Type
    IPO
  • Transaction Amount
    $60,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms